Azitra (AZTR) Other Non-Current Assets (2022 - 2026)
Azitra (AZTR) reported Other Non-Current Assets of $119951.0 for Q1 2026, up 155.53% on a YoY basis from $46942.0 in Q1 2025, and down 82.36% quarter-over-quarter from $679908.0 in Q4 2025.
Azitra (AZTR) Other Non-Current Assets (2022 - 2026) Analysis & Trends
Azitra has reported Other Non-Current Assets for 5 years, with the latest figure at $119951.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Assets rose 155.53% year-over-year to $119951.0; the trailing twelve-month figure through Mar 2026 stood at $119951.0 (up 155.53% YoY), and the FY2025 full-year result was $679908.0, up 1348.43% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $119951.0, down from $679908.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $920001.0 in Q2 2023, with the low at $46941.0 in Q4 2024.
- Historically, Other Non-Current Assets has averaged $480884.7 across 5 years, with a median of $644505.0 in 2025.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets tumbled 93.68% — and 2025, when it soared 1348.43%.
- Azitra's Other Non-Current Assets stood at $800831.0 in 2022, then fell by 7.32% to $742229.0 in 2023, then plunged by 93.68% to $46941.0 in 2024, then soared by 1348.43% to $679908.0 in 2025, then sank by 82.36% to $119951.0 in 2026.
- The last three Other Non-Current Assets figures came in at $119951.0 (Q1 2026), $679908.0 (Q4 2025), and $47239.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | 119,951.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 119,951.00 |
| Dec 31, 2025 | 679,908.00 |
| Sep 30, 2025 | 47,239.00 |
| Jun 30, 2025 | 644,505.00 |
| Mar 31, 2025 | 46,942.00 |
| Dec 31, 2024 | 46,941.00 |
| Sep 30, 2024 | 536,390.00 |
| Jun 30, 2024 | 882,223.00 |
| Mar 31, 2024 | 47,541.00 |
| Dec 31, 2023 | 742,229.00 |
| Sep 30, 2023 | 736,800.00 |
| Jun 30, 2023 | 920,001.00 |
| Dec 31, 2022 | 800,831.00 |